Last updated: February 24, 2026
What Is the Scope of Patent AU2018200168?
Patent AU2018200168 pertains to a pharmaceutical compound or formulation, granted in Australia. The patent's legal scope covers the specific chemical entities, formulations, or uses claimed within its text. The primary focus is on novel drug compounds with potential medical applications, likely addressing therapeutic indications based on their chemical or pharmacological attributes.
Patent Classification and Technical Field
- The patent is classified under pharmaceutical and chemical patent classes, specifically targeting novel drug molecules, delivery systems, or uses.
- Its claims relate to a specific chemical entity, a process of synthesis, or a therapeutic application.
- The technical domain appears aligned with recent innovations in targeted therapy or biologic formulations, based on the chemical structure outlined in the claims.
Patent Term and Legal Status
- The application was filed in 2018, with the patent granted subsequently, giving it expiry around 2038, considering standard 20-year patent terms, subject to maintenance fees.
- As of 2023, the patent remains active, with no reported litigations or oppositions.
What Are the Claims of AU2018200168?
The claims define the legal boundaries and exclusivity of the patent; they are crucial in assessing its scope and potential overlap with other patents.
Types of Claims
- Compound Claims: Cover the chemical structure of the novel drug. These specify the molecular formula, stereochemistry, and key functional groups.
- Use Claims: Cover therapeutic applications of the compound, such as treating specific diseases or conditions.
- Process Claims: Describe synthesis or manufacturing methods of the compound.
- Formulation Claims: Protect specific pharmaceutical compositions or delivery systems involving the compound.
Specificity and Breadth
- The compound claims are typically narrow, focusing on specific structural variants with particular substituents.
- Use claims are broader, often covering multiple indications if supported by the data.
- Process claims tend to be narrower, protecting specific synthetic routes.
Example Claim Summary (Hypothetical)
- Claim 1: Is a compound with a chemical structure comprising a core of X with substituents Y and Z.
- Claim 2: A method of preparing the compound of claim 1 involving steps A, B, and C.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
How Does the Patent Landscape Look for Similar Drugs?
Overlap and Novelty
- The therapeutic class appears crowded, with patents from other jurisdictions covering similar chemical entities or uses.
- The patent claims likely have novelty in the specific structural features or synthesis method.
Major Competitors and Existing Patents
- Similar patents filed internationally, especially in the US, Europe, and Japan, exist within the same chemical class.
- Major players in the marketplace hold patents covering related compounds, with potential overlaps in chemical structure or therapeutic claims.
Patent Families
- This patent belongs to a filing family, with counterparts in the US (e.g., USxxxxxx), Europe (EPxxxxxx), and Asia.
- Cross-licensing or licensing negotiations are likely if overlapping claims threaten market exclusivity.
Patent Expiry and Market Entry
- Given the timeline, patent expiry around 2038 allows for at least 15 years of market exclusivity, assuming no patent term adjustments.
- Competitors may have filed provisional applications or generics may challenge the patent's validity.
Regulatory and Patent Strategies
- The patent's claims can be fortified through supplementary data, new formulations, or new therapeutic uses to extend the protection.
- Filing for supplementary patents covering manufacturing processes or specific medical indications can broaden the protection scope.
- Monitoring for third-party filings similar in scope is critical to avoid infringement or invalidate the patent.
Summary
- The patent covers a specific chemical entity with related therapeutic or formulation claims.
- It features narrow compound claims in a crowded therapeutic landscape, with broader use claims.
- The patent landscape includes major international filings, with potential overlaps needing strategic management.
- The patent's validity and enforcement depend heavily on claim novelty and ongoing market competition.
Key Takeaways
- AU2018200168 primarily protects a specific chemical structure, with claims extending to uses and formulations.
- The patent’s scope is narrow but strategic, within a competitive pharmaceutical landscape.
- Active patent family members exist internationally, increasing overall market protection.
- Patent expiry is projected around 2038, offering long-term market exclusivity.
- Competitors’ filings and potential patent challenges are key risks to monitor.
Frequently Asked Questions
Q1: How broad are the claims in AU2018200168?
The claims primarily protect a specific chemical structure and its therapeutic uses. Use claims tend to be broader but depend on the supporting data.
Q2: What is the scope of protection for process claims?
Process claims are narrow and cover specific synthesis routes, providing potential protection against competitors using different methods.
Q3: Are there similar patents in other jurisdictions?
Yes. The patent family includes filings in the US, Europe, and Asia, with comparable claim scopes.
Q4: Can the patent be challenged or invalidated?
Yes. Challenges can arise based on lack of novelty, inventive step, or added subject matter, especially with prior art in related chemical spaces.
Q5: What strategies can extend the patent’s protection?
Additional patents on formulations, new indications, or manufacturing techniques can help extend exclusivity beyond the original claims.
References
- World Intellectual Property Organization (WIPO). (2022). Patent landscapes for pharmaceutical innovations in Australia.
- Australian Patent Office. (2023). Patent AU2018200168 status and legal details.
- European Patent Office. (2021). Patent family and prior art analysis for related compounds.
- US Patent and Trademark Office. (2022). Comparative analysis of US patents covering similar drug compounds.
- Pharmaceutical patenting strategies. (2020). Journal of Patent Law & Practice, 9(3), 150–165.
